Literature DB >> 31980475

Hyperviscosity-related splenic infarction, gastrointestinal ischaemia-reperfusion injury and transient dysarthria in a patient with distributive shock due to idiopathic systemic capillary leak syndrome (Clarkson's syndrome).

Jelle Alexander van Erven1, Jolanda Schrama1, Daan Albert Robertus Castelijn2.   

Abstract

Clarkson's syndrome, also known as idiopathic systemic capillary leak syndrome, is characterised by vascular hyperpermeability resulting in intravascular hypovolaemia and shock. A clinician should consider the diagnosis if other causes of shock, for example, sepsis and anaphylaxis, are ruled out and concomitant hyperviscosity is not caused by a myeloproliferative disease. Here, we describe a patient presenting with severe plasma leakage and assumable blood hyperviscosity leading to splenic infarction, gastrointestinal ischaemia-reperfusion syndrome and transient dysarthria. Our patient was first suspected of polycythaemia vera and phlebotomies were performed. Awareness of this syndrome and subsequent correct treatment is essential to prevent complications and to reduce mortality. As in our patient, most patients with Clarkson's syndrome have a monoclonal gammopathy, light-chain-type kappa. Prophylactic treatment with intravenous immunoglobulin (IVIg) is advised to prevent recurrence of capillary leak. Our patient did not suffer from another symptomatic episode after starting IVIg. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gastroenterology; haematology (incl blood transfusion); immunology; intensive care; malignant and benign haematology

Mesh:

Substances:

Year:  2020        PMID: 31980475      PMCID: PMC7021132          DOI: 10.1136/bcr-2019-232500

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Cyclical edema and shock due to increased capillary permeability.

Authors:  B CLARKSON; D THOMPSON; M HORWITH; E H LUCKEY
Journal:  Am J Med       Date:  1960-08       Impact factor: 4.965

2.  Vascular endothelial growth factor in systemic capillary leak syndrome.

Authors:  Willem Joost Lesterhuis; Alexander J Rennings; William P Leenders; Arjan Nooteboom; Cornelis J Punt; Fred C Sweep; Peter Pickkers; Anneke Geurts-Moespot; Hanneke W Van Laarhoven; Johan Van der Vlag; Jo H Berden; Cor T Postma; Jos W Van der Meer
Journal:  Am J Med       Date:  2009-06       Impact factor: 4.965

Review 3.  Mechanisms of action of intravenous immune globulin in immune-mediated diseases.

Authors:  L Mouthon; S V Kaveri; S H Spalter; S Lacroix-Desmazes; C Lefranc; R Desai; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1996-05       Impact factor: 4.330

4.  Effects of vascular endothelial growth factor on hemodynamics and cardiac performance.

Authors:  R Yang; G R Thomas; S Bunting; A Ko; N Ferrara; B Keyt; J Ross; H Jin
Journal:  J Cardiovasc Pharmacol       Date:  1996-06       Impact factor: 3.105

5.  Synchronized changes in serum vascular endothelial growth factor during the clinical course of chronic systemic capillary leak syndrome.

Authors:  Yoshiaki Kinoshita; Shunji Kasaoka; Motoki Fujita; Chiyomi Oshima; Yoshikatsu Kawamura; Ryosuke Tsuruta; Tsuyoshi Maekawa
Journal:  Intern Med       Date:  2010-04-15       Impact factor: 1.271

6.  Clinical Presentation, Management, and Prognostic Factors of Idiopathic Systemic Capillary Leak Syndrome: A Systematic Review.

Authors:  Tae Seong Eo; Kyung Ju Chun; Su Jung Hong; Ji Young Kim; I Re Lee; Keum Hwa Lee; Michael Eisenhut; Andreas Kronbichler; Jae Il Shin
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-19

7.  Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome).

Authors:  Zhihui Xie; Chandra C Ghosh; Roshni Patel; Shoko Iwaki; Donna Gaskins; Celeste Nelson; Nina Jones; Philip R Greipp; Samir M Parikh; Kirk M Druey
Journal:  Blood       Date:  2012-03-12       Impact factor: 22.113

8.  Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.

Authors:  Marc Pineton de Chambrun; Marie Gousseff; Wladimir Mauhin; Jean-Christophe Lega; Marc Lambert; Sophie Rivière; Antoine Dossier; Marc Ruivard; François Lhote; Gilles Blaison; Laurent Alric; Christian Agard; David Saadoun; Julie Graveleau; Martin Soubrier; Marie-Josée Lucchini-Lecomte; Christine Christides; Annick Bosseray; Hervé Levesque; Jean-François Viallard; Nathalie Tieulie; Pierre-Yves Lovey; Sylvie Le Moal; Béatrice Bibes; Giuseppe Malizia; Pierre Abgueguen; François Lifermann; Jacques Ninet; Pierre-Yves Hatron; Zahir Amoura
Journal:  Am J Med       Date:  2017-06-09       Impact factor: 4.965

9.  Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

Authors:  Ismo Vajanto; Tuomas T Rissanen; Juha Rutanen; Mikko O Hiltunen; Tiina T Tuomisto; Katja Arve; Outi Närvänen; Hannu Manninen; Heikki Räsänen; Mikko Hippeläinen; Esko Alhava; Seppo Ylä-Herttuala
Journal:  J Gene Med       Date:  2002 Jul-Aug       Impact factor: 4.565

Review 10.  Vascular endothelial growth factors and vascular permeability.

Authors:  David O Bates
Journal:  Cardiovasc Res       Date:  2010-04-16       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.